Intimation of Closure of Trading Window for the quarter ending 31st March,2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indrayani Biotech Ltd has informed BSE that the trading window for its securities will be closed from April 01, 2026, until 48 hours after the announcement of the audited financial results for the quarter and full year ending March 31, 2026. During this period, directors, designated persons, and their immediate relatives are prohibited from trading in the company's shares. The company has also updated the NSDL portal to freeze PANs at the security level for designated persons as per SEBI's July 2023 circular. The date of the board meeting to declare the audited results has not yet been announced and will be communicated later.
This is a routine compliance filing required under SEBI insider trading regulations ahead of the FY26 audited results. It has no direct impact on shareholders or the stock price, but signals that the company's full-year and Q4 FY26 financial results will be announced in the coming weeks.